Aerogen Pharma

Aerogen Pharma is a specialty pharmaceutical company and the drug development arm of the Aerogen Group, the global leader in high-performance aerosol drug delivery. The company focuses on developing 'aero-therapeutics'—proprietary drug-device combination products that utilize Aerogen's patented vibrating mesh technology to deliver life-saving medications directly to the lungs of critically ill patients. The company's primary focus is on neonatal and pediatric respiratory care, specifically addressing Respiratory Distress Syndrome (RDS) in preterm infants. By repurposing proven therapeutic molecules for non-invasive inhalation, Aerogen Pharma aims to replace invasive intubation and mechanical ventilation with safer, more effective aerosolized treatments.